Rights and permissions
About this article
Cite this article
The Big Three of US Pharma. Pharmaceutical Innovation 11, 46–49 (2002). https://doi.org/10.1007/BF03265440
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03265440
Pfizer, Merck & Co. and GlaxoSmithKline
7 Accesses
This is a preview of subscription content, log in via an institution to check access.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Rent this article via DeepDyve
The Big Three of US Pharma. Pharmaceutical Innovation 11, 46–49 (2002). https://doi.org/10.1007/BF03265440
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03265440
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative